News News Select Year All Years 2026 (24) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 496 Results Page 36 of 50« First«...102030...3435363738...50...»Last » April 11, 2016 DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy April 7, 2016 DBV Technologies Reports Full Year 2015 Financial Results March 6, 2016 Additional Phase IIb Trial Results with Viaskin Peanut Presented at the 2016 AAAAI Meeting Continue to Support Treatment Safety, Efficacy and Compliance March 4, 2016 DBV Technologies Announces Presentation from NIAID-sponsored CoFAR6 Phase II Trial Reaffirming Viaskin® Peanut Safety and Efficacy March 1, 2016 DBV Technologies to Attend Upcoming Investor Conferences and Events February 25, 2016 DBV Technologies Announces Publication of Phase Ib Trial Results in the Journal of Allergy and Clinical Immunology (JACI) Supporting Safety and Tolerability of Viaskin® Peanut February 15, 2016 DBV Technologies Reports December 31, 2015, Cash Position February 10, 2016 DBV Technologies to Present New Data at the 2016 AAAAI Annual Meeting February 8, 2016 DBV Technologies to Present at the LEERINK Partners 5th Annual Global Healthcare Conference January 26, 2016 DBV Technologies Proudly Welcomes Edward Jordan as Senior Vice President Commercial Operations North America Page 36 of 50« First«...102030...3435363738...50...»Last »
